The FDA is finalizing plans for a suicidality warning on 11 epilepsy drugs which topped $8B in...


The FDA is finalizing plans for a suicidality warning on 11 epilepsy drugs which topped $8B in sales last year. Companies affected include GSK, ABT, JNJ, NVS and PFE. The latter openly disputes the move.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs